Nitrite signaling in pulmonary hypertension: Mechanisms of bioactivation, signaling, and therapeutics

Antioxidants and Redox Signaling

Volumn 18, Issue 14, 2013, Pages 1797-1809

  Bueno, Marta ^a   Wang, Jun ^a   Mora, Ana L ^a,b   Gladwin, Mark T ^a,b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME C; CYTOCHROME C OXIDASE; DEOXYHEMOGLOBIN; MOLYBDOPTERIN; MYOGLOBIN; NEUROGLOBIN; NITRATE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRITE; SYNTHETASE;

ANGIOGENESIS; ANTIMICROBIAL ACTIVITY; AUTOOXIDATION; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; CYANOSIS; DRUG BIOAVAILABILITY; DRUG FORMULATION; ELECTRON TRANSPORT; ENZYME ACTIVITY; HEART MUSCLE ISCHEMIA; HUMAN; HYPERTENSION; IMMUNE RESPONSE; LUNG ARTERY PRESSURE; LUNG VASCULAR RESISTANCE; MACROPHAGE; MITOCHONDRIAL RESPIRATION; NEUROTRANSMISSION; NONHUMAN; OXIDATION; PRIORITY JOURNAL; PROTON TRANSPORT; PULMONARY HYPERTENSION; REVIEW; SICKLE CELL ANEMIA; SIDE EFFECT; SIGNAL TRANSDUCTION;

ANIMALS; HUMANS; HYPERTENSION, PULMONARY; NITRATES; NITRIC OXIDE; NITRITES; SIGNAL TRANSDUCTION; VASCULAR DISEASES;

ANIMALIA;

EID: 84875923439     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2012.4833     Document Type: Review

References (87)

1. Aamand R, Dalsgaard T, Jensen FB, Simonsen U, Roepstorff A, and Fago A. Generation of nitric oxide from nitrite by carbonic anhydrase: a possible link between metabolic activity and vasodilation. Am J Physiol Heart Circ Physiol 297: H2068-H2074, 2009.
2. Alef MJ, Vallabhaneni R, Carchman E, Morris SM, Jr., Shiva S, Wang Y, Kelley EE, Tarpey MM, Gladwin MT, Tzeng E, and Zuckerbraun BS. Nitrite-generated NO circumvents dysregulated arginine/NOS signaling to protect against in-timal hyperplasia in Sprague-Dawley rats. J Clin Invest 121: 1646-1656, 2011.
3. Ardehali A, Hughes K, Sadeghi A, Esmailian F, Marelli D, Moriguchi J, Hamilton MA, Kobashigawa J, and Laks H. Inhaled nitric oxide for pulmonary hypertension after heart transplantation. Transplantation 72: 638-641, 2001.
4. Basu S, Azarova NA, Font MD, King SB, Hogg N, Gladwin MT, Shiva S, and Kim-Shapiro DB. Nitrite reductase activity of cytochrome c. J Biol Chem 283: 32590-32597, 2008.
5. 3 by the concerted nitrite re-ductase and anhydrase activity of hemoglobin. Nat Chem Biol 3: 785-794, 2007.
6. Belikova NA, Vladimirov YA, Osipov AN, Kapralov AA, Tyurin VA, Potapovich MV, Basova LV, Peterson J, Kurni-kov IV, and Kagan VE. Peroxidase activity and structural transitions of cytochrome c bound to cardiolipin-containing membranes. Biochemistry 45: 4998-5009, 2006.
7. Benamar A, Rolletschek H, Borisjuk L, Avelange-Macherel MH, Curien G, Mostefai HA, Andriantsitohaina R, and Macherel D. Nitrite-nitric oxide control of mitochondrial respiration at the frontier of anoxia. Biochim Biophys Acta 1777: 1268-1275, 2008.
8. Benjamin N, O'Driscoll F, Dougall H, Duncan C, Smith L, Golden M, and McKenzie H. Stomach NO synthesis. Nature 368: 502, 1994.
9. Botha P, Jeyakanthan M, Rao JN, Fisher AJ, Prabhu M, Dark JH, and Clark SC. Inhaled nitric oxide for modulation of ischemia-reperfusion injury in lung transplantation. J Heart Lung Transplant 26: 1199-1205, 2007.
10. Carlsson S, Weitzberg E, Wiklund P, and Lundberg JO. Intravesical nitric oxide delivery for prevention of catheter-associated urinary tract infections. Antimicrob Agents Che-mother 49: 2352-2355, 2005.
11. Casey DB, Badejo AM, Jr., Dhaliwal JS, Murthy SN, Hyman AL, Nossaman BD, and Kadowitz PJ. Pulmonary vasodilator responses to sodium nitrite are mediated by an allopurinol-sensitive mechanism in the rat. Am J Physiol Heart Circ Physiol 296: H524-H533, 2009.
12. Castello PR, David PS, McClure T, Crook Z, and Poyton RO. Mitochondrial cytochrome oxidase produces nitric oxide under hypoxic conditions: implications for oxygen sensing and hypoxic signaling in eukaryotes. Cell Metab 3: 277-287, 2006.
13. Chakrapani H, Gorczynski MJ, and King SB. Allylic nitro compounds as nitrite donors. J Am Chem Soc 128: 16332-16337, 2006.
14. Champion HC, Bivalacqua TJ, Greenberg SS, Giles TD, Hyman AL, and Kadowitz PJ. Adenoviral gene transfer of endothelial nitric-oxide synthase (eNOS) partially restores normal pulmonary arterial pressure in eNOS-deficient mice. Proc Natl Acad Sci USA 99: 13248-13253, 2002.
15. Clark RH, Kueser TJ, Walker MW, Southgate WM, Huckaby JL, Perez JA, Roy BJ, Keszler M, and Kinsella JP. Low-dose nitric oxide therapy for persistent pulmonary hypertension of the newborn. Clinical Inhaled Nitric Oxide Research Group. N Engl J Med 342: 469-474, 2000.
16. Cosby K, Partovi KS, Crawford JH, Patel RP, Reiter CD, Martyr S, Yang BK, Waclawiw MA, Zalos G, Xu X, Huang KT, Shields H, Kim-Shapiro DB, Schechter AN, Cannon RO, 3rd, and Gladwin MT. Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the human circulation. Nat Med 9: 1498-1505, 2003.
17. Dejam A, Hunter CJ, Tremonti C, Pluta RM, Hon YY, Grimes G, Partovi K, Pelletier MM, Oldfield EH, Cannon RO, 3rd, Schechter AN, and Gladwin MT. Nitrite infusion in humans and nonhuman primates: endocrine effects, pharmacokinetics, and tolerance formation. Circulation 116: 1821-1831, 2007.
18. Dellinger RP, Trzeciak SW, Criner GJ, Zimmerman JL, Taylor RW, Usansky H, Young J, and Goldstein B. Association between inhaled nitric oxide treatment and long-term pulmonary function in survivors of acute respiratory distress syndrome. Crit Care 16: R36, 2012.
19. Dezfulian C, Raat N, Shiva S, and Gladwin MT. Role of the anion nitrite in ischemia-reperfusion cytoprotection and therapeutics. Cardiovasc Res 75: 327-338, 2007.
20. Dezfulian C, Shiva S, Alekseyenko A, Pendyal A, Beiser DG, Munasinghe JP, Anderson SA, Chesley CF, Vanden Hoek TL, and Gladwin MT. Nitrite therapy after cardiac arrest reduces reactive oxygen species generation, improves cardiac and neurological function, and enhances survival via reversible inhibition of mitochondrial complex I. Circulation 120: 897-905, 2009.
21. Donohue PK, Gilmore MM, Cristofalo E, Wilson RF, Weiner JZ, Lau BD, Robinson KA, and Allen MC. Inhaled nitric oxide in preterm infants: a systematic review. Pediatrics 127: e414-e422, 2011.
22. Doyle MP, Pickering RA, DeWeert TM, Hoekstra JW, and Pater D. Kinetics and mechanism of the oxidation of human deoxyhemoglobin by nitrites. J Biol Chem 256: 12393-12398, 1981.
23. Duranski MR, Greer JJ, Dejam A, Jaganmohan S, Hogg N, Langston W, Patel RP, Yet SF, Wang X, Kevil CG, Gladwin MT, and Lefer DJ. Cytoprotective effects of nitrite during in vivo ischemia-reperfusion of the heart and liver. J Clin Invest 115: 1232-1240, 2005.
24. Egemnazarov B, Schermuly RT, Dahal BK, Elliott GT, Ho-glen NC, Surber MW, Weissmann N, Grimminger F, Seeger W, and Ghofrani HA. Nebulization of the acidified sodium nitrite formulation attenuates acute hypoxic pulmonary va-soconstriction. Respir Res 11: 81, 2010.
25. Forman D, Aldabbagh S, and Doll R. Nitrates, nitrites and gastric-cancer in Great-Britain. Nature 313: 620-625, 1985.
26. Germann P, Ziesche R, Leitner C, Roeder G, Urak G, Zimpfer M, and Sladen R. Addition of nitric oxide to oxygen improves cardiopulmonary function in patients with severe COPD. Chest 114: 29-35, 1998.
27. Gilchrist M, Shore AC, and Benjamin N. Inorganic nitrate and nitrite and control of blood pressure. Cardiovasc Res 89: 492-498, 2011.
28. Gladwin MT, Grubina R, and Doyle MP. The new chemical biology of nitrite reactions with hemoglobin: R-state catalysis, oxidative denitrosylation, and nitrite reductase/anhy-drase. Acc Chem Res 42: 157-167, 2009.
29. Gladwin MT and Kim-Shapiro DB. The functional nitrite reductase activity of the heme-globins. Blood 112: 2636-2647, 2008.
30. Gladwin MT, Schechter AN, Kim-Shapiro DB, Patel RP, Hogg N, Shiva S, Cannon RO, 3rd, Kelm M, Wink DA, Espey MG, Oldfield EH, Pluta RM, Freeman BA, Lancaster JR, Jr., Feelisch M, and Lundberg JO. The emerging biology of the nitrite anion. Nat Chem Biol 1: 308-314, 2005.
31. Gonzalez FM, Shiva S, Vincent PS, Ringwood LA, Hsu LY, Hon YY, Aletras AH, Cannon RO, 3rd, Gladwin MT, and Arai AE. Nitrite anion provides potent cytoprotective and antiapoptotic effects as adjunctive therapy to reperfusion for acute myocardial infarction. Circulation 117: 2986-2994, 2008.
32. Goret L, Tanguy S, Guiraud I, Dauzat M, and Obert P. Acute administration of L-arginine restores nitric oxide-mediated relaxation in isolated pulmonary arteries from pulmonary hypertensive exercise trained rats. Eur J Pharmacol 581: 148-156, 2008.
33. Griffiths MJ and Evans TW. Inhaled nitric oxide therapy in adults. N Engl J Med 353: 2683-2695, 2005.
34. Harris CM and Massey V. The oxidative half-reaction of xanthine dehydrogenase with NAD; reaction kinetics and steady-state mechanism. J Biol Chem 272: 28335-28341, 1997.
35. Hendgen-Cotta UB, Merx MW, Shiva S, Schmitz J, Becher S, Klare JP, Steinhoff HJ, Goedecke A, Schrader J, Gladwin MT, Kelm M, and Rassaf T. Nitrite reductase activity of myo-globin regulates respiration and cellular viability in myo-cardial ischemia-reperfusion injury. Proc Natl Acad Sci USA 105: 10256-10261, 2008.
36. Hibbs JB, Jr., Taintor RR, and Vavrin Z. Macrophage cyto-toxicity: role for L-arginine deiminase and imino nitrogen oxidation to nitrite. Science 235: 473-476, 1987.
37. Huang Z, Shiva S, Kim-Shapiro DB, Patel RP, Ringwood LA, Irby CE, Huang KT, Ho C, Hogg N, Schechter AN, and Gladwin MT. Enzymatic function of hemoglobin as a nitrite reductase that produces NO under allosteric control. J Clin Invest 115: 2099-2107, 2005.
38. Hunter CJ, Dejam A, Blood AB, Shields H, Kim-Shapiro DB, Machado RF, Tarekegn S, Mulla N, Hopper AO, Schechter AN, Power GG, and Gladwin MT. Inhaled nebulized nitrite is a hypoxia-sensitive NO-dependent selective pulmonary vasodilator. Nat Med 10: 1122-1127, 2004.
39. Ichinose F, Roberts JD, Jr., and Zapol WM. Inhaled nitric oxide: a selective pulmonary vasodilator: current uses and therapeutic potential. Circulation 109: 3106-3111, 2004.
40. Ignarro LJ, Buga GM, Wood KS, Byrns RE, and Chaudhuri G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA 84: 9265-9269, 1987.
41. Iyengar R, Stuehr DJ, and Marletta MA. Macrophage synthesis of nitrite, nitrate, and N-nitrosamines: precursors and role of the respiratory burst. Proc Natl Acad Sci USA 84: 6369-6373, 1987.
42. Jung KH, Chu K, Ko SY, Lee ST, Sinn DI, Park DK, Kim JM, Song EC, Kim M, and Roh JK. Early intravenous infusion of sodium nitrite protects brain against in vivo ischemia-re-perfusion injury. Stroke 37: 2744-2750, 2006.
43. Jung KH, Chu K, Lee ST, Kim JM, Park DK, Kim M, Lee SK, and Roh JK. Tolerated nitrite therapy in experimental in-tracerebral hemorrhage: Rationale of nitrite therapy in a broad range of hyperacute strokes. Neurochem Int 59: 5-9, 2011.
44. Jung KH, Chu K, Lee ST, Park HK, Kim JH, Kang KM, Kim M, Lee SK, and Roh JK. Augmentation of nitrite therapy in cerebral ischemia by NMDA receptor inhibition. Biochem Biophys Res Commun 378: 507-512, 2009.
45. Jung KH, Chu K, Lee ST, Sunwoo JS, Park DK, Kim JH, Kim S, Lee SK, Kim M, and Roh JK. Effects of long term nitrite therapy on functional recovery in experimental ischemia model. Biochem Biophys Res Commun 403: 66-72, 2010.
46. Kapil V, Milsom AB, Okorie M, Maleki-Toyserkani S, Akram F, Rehman F, Arghandawi S, Pearl V, Benjamin N, Louko-georgakis S, Macallister R, Hobbs AJ, Webb AJ, and Ahlu-walia A. Inorganic nitrate supplementation lowers blood pressure in humans: role for nitrite-derived NO. Hypertension 56: 274-281, 2010.
47. Kelley EE, Hundley NJ, and Tarpey MM. Oxygen dependence of XOR nitrite reductase activity. Free Radic Biol Med 47: S32, 2009.
48. Kumar D, Branch BG, Pattillo CB, Hood J, Thoma S, Simpson S, Illum S, Arora N, Chidlow JH, Jr., Langston W, Teng X, Lefer DJ, Patel RP, and Kevil CG. Chronic sodium nitrite therapy augments ischemia-induced angiogene-sis and arteriogenesis. Proc Natl Acad Sci USA 105: 7540-7545, 2008.
49. Larsen FJ, Ekblom B, Sahlin K, Lundberg JO, and Weitzberg E. Effects of dietary nitrate on blood pressure in healthy volunteers. N Engl J Med 355: 2792-2793, 2006.
50. Li H, Kundu TK, and Zweier JL. Characterization of the magnitude and mechanism of aldehyde oxidase-mediated nitric oxide production from nitrite. J Biol Chem 284: 33850-33858, 2009.
51. Li H, Samouilov A, Liu X, and Zweier JL. Characterization of the magnitude and kinetics of xanthine oxidase-catalyzed nitrite reduction. Evaluation of its role in nitric oxide generation in anoxic tissues. J Biol Chem 276: 24482-24489, 2001.
52. Li H, Samouilov A, Liu X, and Zweier JL. Characterization of the effects of oxygen on xanthine oxidase-mediated nitric oxide formation. J Biol Chem 279: 16939-16946, 2004.
53. 2 within the hy-drophobic interior of biological membranes. Proc Natl Acad Sci USA 95: 2175-2179, 1998.
54. Lo V and Cullen C. (Eds). Medieval Chinese Medicine: the Dunhuang Medical Manuscripts. New York: Routledge, 2004.
55. Lundberg JO, Weitzberg E, and Gladwin MT. The nitrate-nitrite-nitric oxide pathway in physiology and therapeutics. Nat Rev Drug Discov 7: 156-167, 2008.
56. Lundberg JO, Weitzberg E, Lundberg JM, and Alving K. Intragastric nitric oxide production in humans: measurements in expelled air. Gut 35: 1543-1546, 1994.
57. Mack AK, McGowan Ii VR, Tremonti CK, Ackah D, Barnett C, Machado RF, Gladwin MT, and Kato GJ. Sodium nitrite promotes regional blood flow in patients with sickle cell disease: A phase I/II study. Br J Haematol 142: 971-978, 2008.
58. McCarty MF. Potential utility of full-spectrum antioxidant therapy, citrulline, and dietary nitrate in the management of sickle cell disease. Med Hypotheses 74: 1055-1058, 2010.
59. Moore LL, Bradlee ML, Singer MR, Qureshi MM, Buendia JR, and Daniels SR. Dietary Approaches to Stop Hypertension (DASH) eating pattern and risk of elevated blood pressure in adolescent girls. Br J Nutr: 1-8, 2012.
60. Murillo D, Kamga C, Mo L, and Shiva S. Nitrite as a mediator of ischemic preconditioning and cytoprotection. Nitric Oxide 25: 70-80, 2011.
61. Ormerod AD, Shah AA, Li H, Benjamin NB, Ferguson GP, and Leifert C. An observational prospective study of topical acidified nitrite for killing methicillin-resistant Staphylococcus aureus (MRSA) in contaminated wounds. BMC Res Notes 4: 458, 2011.
62. Palmer RM, Ferrige AG, and Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327: 524-526, 1987.
63. Papapetropoulos A, Garcia-Cardena G, Madri JA, and Sessa WC. Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells. J Clin Invest 100: 3131-3139, 1997.
64. Pattillo CB, Bir S, Rajaram V, and Kevil CG. Inorganic nitrite and chronic tissue ischaemia: a novel therapeutic modality for peripheral vascular diseases. Cardiovasc Res 89: 533-541, 2011.
65. Pepke-Zaba J, Higenbottam TW, Dinh-Xuan AT, Stone D, and Wallwork J. Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension. Lancet 338: 1173-1174, 1991.
66. Pluta RM, Dejam A, Grimes G, Gladwin MT, and Oldfield EH. Nitrite infusions to prevent delayed cerebral vasospasm in a primate model of subarachnoid hemorrhage. JAMA 293: 1477-1484, 2005.
67. Pluta RM, Oldfield EH, Bakhtian KD, Fathi AR, Smith RK, Devroom HL, Nahavandi M, Woo S, Figg WD, and Lonser RR. Safety and feasibility of long-term intravenous sodium nitrite infusion in healthy volunteers. PLoS One 6: e14504, 2011.
68. Rassaf T, Preik M, Kleinbongard P, Lauer T, Heiss C, Strauer BE, Feelisch M, and Kelm M. Evidence for in vivo transport of bioactive nitric oxide in human plasma. J Clin Invest 109: 1241-1248, 2002.
69. Reddy D, Lancaster JR, Jr., and Cornforth DP. Nitrite inhibition of Clostridium botulinum: electron spin resonance detection of iron-nitric oxide complexes. Science 221: 769-770, 1983.
70. Shiva S, Huang Z, Grubina R, Sun J, Ringwood LA, Ma-cArthur PH, Xu X, Murphy E, Darley-Usmar VM, and Gladwin MT. Deoxymyoglobin is a nitrite reductase that generates nitric oxide and regulates mitochondrial respiration. Circ Res 100: 654-661, 2007.
71. Shiva S, Rassaf T, Patel RP, and Gladwin MT. The detection of the nitrite reductase and NO-generating properties of haemoglobin by mitochondrial inhibition. Cardiovasc Res 89: 566-573, 2011.
72. Shiva S, Sack MN, Greer JJ, Duranski M, Ringwood LA, Burwell L, Wang X, MacArthur PH, Shoja A, Raghavachari N, Calvert JW, Brookes PS, Lefer DJ, and Gladwin MT. Nitrite augments tolerance to ischemia/reperfusion injury via the modulation of mitochondrial electron transfer. J Exp Med 204: 2089-2102, 2007.
73. Shiva S, Wang X, Ringwood LA, Xu X, Yuditskaya S, An-navajjhala V, Miyajima H, Hogg N, Harris ZL, and Gladwin MT. Ceruloplasmin is a NO oxidase and nitrite synthase that determines endocrine NO homeostasis. Nat Chem Biol 2: 486-493, 2006.
74. Stuehr DJ and Marletta MA. Mammalian nitrate biosynthesis: mouse macrophages produce nitrite and nitrate in response to Escherichia coli lipopolysaccharide. Proc Natl Acad Sci USA 82: 7738-7742, 1985.
75. Tabima DM, Frizzell S, and Gladwin MT. Reactive oxygen and nitrogen species in pulmonary hypertension. Free Radic Biol Med 52: 1970-1986, 2012.
76. Tannenbaum SR, Fett D, Young VR, Land PD, and Bruce WR. Nitrite and nitrate are formed by endogenous synthesis in the human intestine. Science 200: 1487-1489, 1978.
77. Tiso M, Tejero J, Basu S, Azarov I, Wang X, Simplaceanu V, Frizzell S, Jayaraman T, Geary L, Shapiro C, Ho C, Shiva S, Kim-Shapiro DB, and Gladwin MT. Human neuroglobin functions as a redox-regulated nitrite reductase. J Biol Chem 286: 18277-18289, 2011.
78. Vanin AF, Bevers LM, Slama-Schwok A, and van Faassen EE. Nitric oxide synthase reduces nitrite to NO under anoxia. Cell Mol Life Sci 64: 96-103, 2007.
79. Ward MH, deKok TM, Levallois P, Brender J, Gulis G, Nolan BT, VanDerslice J, and International Society for Environmental E. Workgroup report: Drinking-water nitrate and health-recent findings and research needs. Environ Health Perspect 113: 1607-1614, 2005.
80. 2-dependent form (type O). Arch Biochem Biophys 172: 365-379, 1976.
81. Webb AJ, Milsom AB, Rathod KS, Chu WL, Qureshi S, Lovell MJ, Lecomte FM, Perrett D, Raimondo C, Khoshbin E, Ahmed Z, Uppal R, Benjamin N, Hobbs AJ, and Ahluwalia A. Mechanisms underlying erythrocyte and endothelial nitrite reduction to nitric oxide in hypoxia: role for xanthine oxidoreductase and endothelial nitric oxide synthase. Circ Res 103: 957-964, 2008.
82. Weitzberg E and Lundberg JO. Nonenzymatic nitric oxide production in humans. Nitric Oxide 2: 1-7, 1998.
83. Wood KC, Hsu LL, and Gladwin MT. Sickle cell disease vasculopathy: a state of nitric oxide resistance. Free Radic Biol Med 44: 1506-1528, 2008.
84. Zhang Z, Naughton DP, Blake DR, Benjamin N, Stevens CR, Winyard PG, Symons MC, and Harrison R. Human xanthine oxidase converts nitrite ions into nitric oxide (NO). Biochem Soc Trans 25: 524S, 1997.
85. Zuckerbraun BS, George P, and Gladwin MT. Nitrite in pulmonary arterial hypertension: therapeutic avenues in the setting of dysregulated arginine/nitric oxide synthase signalling. Cardiovasc Res 89: 542-552, 2011.
86. Zuckerbraun BS, Shiva S, Ifedigbo E, Mathier MA, Mollen KP, Rao J, Bauer PM, Choi JJ, Curtis E, Choi AM, and Gladwin MT. Nitrite potently inhibits hypoxic and inflammatory pulmonary arterial hypertension and smooth muscle proliferation via xanthine oxidoreductase-dependent nitric oxide generation. Circulation 121: 98-109, 2010.
87. Zweier JL, Wang P, Samouilov A, and Kuppusamy P. Enzyme-independent formation of nitric oxide in biological tissues. Nat Med 1: 804-809, 1995.